ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Advicenne

Advicenne (ALDVI)

2.075
0.015
(0.73%)
Closed January 22 11:30AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
2.075
Bid
2.065
Ask
2.08
Volume
9,227
2.03 Day's Range 2.08
0.827 52 Week Range 3.06
Market Cap
Previous Close
2.06
Open
2.08
Last Trade
540
@
2.075
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
26,655
Shares Outstanding
9,933,732
Dividend Yield
-
PE Ratio
-2.92
Earnings Per Share (EPS)
-0.71
Revenue
3.48M
Net Profit
-7.03M

About Advicenne

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Paris, Paris, Fra
Founded
-
Advicenne is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALDVI. The last closing price for Advicenne was 2.06 €. Over the last year, Advicenne shares have traded in a share price range of 0.827 € to 3.06 €.

Advicenne currently has 9,933,732 shares outstanding. The market capitalization of Advicenne is 20.46 € million. Advicenne has a price to earnings ratio (PE ratio) of -2.92.

ALDVI Latest News

Advicenne Announces its 2025 Financial Calendar

Regulatory News: Advicenne (Euronext Growth Paris ALDVI - FR0013296746), a specialty pharmaceutical company dedicated to the development and commercialization of innovative treatments for those...

FDA Grants Orphan Drug Designation to ADV7103 for the Treatment of Cystinuria.

 After distal Renal Tubular Acidosis (dRTA) in December 2022, ADV7103 is granted "orphan drug" status in the United States in cystinuria. A long-awaited milestone for the Company and its...

Advicenne annonce les résultats de son augmentation de capital avec maintien du droit préférentiel de souscription

Souscription à hauteur de 5,7 M€ représentant 95% du montant initial Cemag Invest et Bpifrance détiennent respectivement 18,0% et 21,6% du capital et 17,6% et 23,6% des droits de vote  ...

Advicenne : Lancement d’une augmentation de capital avec maintien du droit préférentiel de souscription afin d’accélérer la croissance en Europe et d’optimiser le développement clinique de ADV7103

Augmentation de capital avec maintien du droit préférentiel de souscription (le “DPS”) d’un montant initial de 6,0 M€, pouvant être porté à 6,9 M€ en cas d’exercice intégral de la clause...

Advicenne annonce le lancement de Sibnayal® au Danemark

Sibnayal® (citrate de potassium / bicarbonate de potassium) commercialisé depuis le 1er Mars 2023 Le prix de référence correspond à un coût de traitement annuel de 15.000 euros par patient...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.0854.271356783921.992.091.964162592.02712794DE
40.0753.7522.21.916231202.0047641DE
120.19510.37234042551.882.251.55266551.9873007DE
260.84568.69918699191.232.390.827411501.66918635DE
52-0.175-7.777777777782.253.060.827456061.83132738DE
156-4.425-68.07692307696.56.80.827278592.76267754DE
260-4.425-68.07692307696.56.80.827278592.76267754DE

ALDVI - Frequently Asked Questions (FAQ)

What is the current Advicenne share price?
The current share price of Advicenne is 2.075 €
How many Advicenne shares are in issue?
Advicenne has 9,933,732 shares in issue
What is the market cap of Advicenne?
The market capitalisation of Advicenne is EUR 20.46M
What is the 1 year trading range for Advicenne share price?
Advicenne has traded in the range of 0.827 € to 3.06 € during the past year
What is the PE ratio of Advicenne?
The price to earnings ratio of Advicenne is -2.92
What is the cash to sales ratio of Advicenne?
The cash to sales ratio of Advicenne is 5.9
What is the reporting currency for Advicenne?
Advicenne reports financial results in EUR
What is the latest annual turnover for Advicenne?
The latest annual turnover of Advicenne is EUR 3.48M
What is the latest annual profit for Advicenne?
The latest annual profit of Advicenne is EUR -7.03M
What is the registered address of Advicenne?
The registered address for Advicenne is 262, RUE DU FAUBOURG, PARIS, PARIS, 75008
What is the Advicenne website address?
The website address for Advicenne is www.advicenne.com
Which industry sector does Advicenne operate in?
Advicenne operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALMASMastrad
0.021 €
(114.29%)
31.14M
ALCYBCybergun
0.0002 €
(100.00%)
18.07M
ALNMRNamR SA
0.22 €
(63.57%)
113.21k
MLAATAzorean Tech
0.16 €
(60.00%)
1.55k
MLGEQGentlemen S Equity SA
0.022 €
(33.33%)
126.29k
MLWEYWeya
0.02 €
(-23.08%)
1.5k
ALNEVNeovacs
0.503 €
(-18.87%)
15.62k
ALBIOBiosynex
1.65 €
(-18.32%)
53.17k
POXELPoxel
0.324 €
(-17.03%)
2.44M
ALVETEGEIRO Pharma
0.0912 €
(-16.33%)
4.95k
ATOAtos SE
0.0022 €
(0.00%)
301.81M
BCPBanco Comercial Portugues SA
0.5132 €
(0.16%)
35.61M
ALMASMastrad
0.0218 €
(122.45%)
24.21M
ALVERVergnet
0.0014 €
(0.00%)
17.57M
ALCYBCybergun
0.0001 €
(0.00%)
15.68M

Discussion

View Full Feed
govprs govprs 36 seconds ago
I think deferred revenue is simply revenue that's is associated to a contract but not earned.  So the example is. Say they sign a contract for 5000 hrs at 10/hr.  Every month they invoice the customer at 1000hrs.  So in month 1 they bill $10000 this shows up on the books at $10000 in revenue and 400
GDVM
StayHumble StayHumble 49 seconds ago
Are10ks💹8ks💹ALJs m00t still? SEC FAV0URS $DBMM💹
Meaning the ruling? +1

Source: https://www.sec.gov/alj/aljdec/2019/id1389cff.pdf
No available sanction appropriate|Thus Proceeding Dismissed.
-------------------------------V. ORDER
DBMM
flipper44 flipper44 2 minutes ago
The only caveat for those general statistics is that we are following Christmas/New year stretch, so, for example, January Wed 29th be more like the 22nd in most or all other months.
NWBO
Golden Cross Golden Cross 2 minutes ago
$LITM Strong upswing underway. MACD crossed bullish today and the RSI is getting ready to enter the Power Zone! Green the last 7 days. This upswing shows no signs of stopping now!

https://investorshub.advfn.com/uimage/uploads/2025/1/22/jzrbylitm.png
LITM
StayHumble StayHumble 2 minutes ago
inCourt UnderOath💹SEC triedBashing $DBMM+Mgmt💹(D0H! Br. at 25-28.)

$DBMM has obtained resources to complete the re-audit, bring the Company current, & continue its timely filings,

DOE once again rejects the Law Judge’s analysis and conclusion that
DBMM
ron_66271 ron_66271 3 minutes ago
Project West Started in the Spring of 2005.

1998, BO litigated the Community Reinvestment Act as an Acorn employee in Chicago against a democrat donor family that held a publicly traded bank. The family made a fortune, but the investors lost everything.

August 2005, Mar
COOP
CrimsonNightRider CrimsonNightRider 3 minutes ago
You are a digital echo chamber for the company.
IQST
Truth and Transparency Truth and Transparency 3 minutes ago
You left out Dean Kehler and Michael Maselli…..literally the largest SHAREHOLDERS of NIOCORP. They brought nothing to the table and walked away being majority shareholders of the company and made Mark and Jim their bitches.

Donald would have fired Mark and Jim after their disastrous
NB
Golden Cross Golden Cross 3 minutes ago
$LITM Strong upswing underway. MACD crossed bullish today and the RSI is getting ready to enter the Power Zone! Green the last 7 days. This upswing shows no signs of stopping now!

https://investorshub.advfn.com/uimage/uploads/2025/1/22/jzrbylitm.png
LITM
Dabeav Dabeav 3 minutes ago
$6.85-$0.0100(-0.15%)
After hours: 5:00:03 PM ET, 01/22/2025
$6.86-$0.1500(-2.14%)
At close: 4:00:00 PM ET, 01/22/2025
Bid
$6.80
Ask
$7.00
FNMA
Carjockey2 Carjockey2 4 minutes ago
Temporarily....but the first crash everyone will run back to their "safe place"..the OTC

>>>>>>Until the OTC can figure out what to do with the currently... very large expert market...good luck with the OTC. Actually..this ticker is one of the few that resemble the old days...lol. Thi
HMBL
StayHumble StayHumble 4 minutes ago
💹wow 80-$99 INCOMING! 💹 UCLA💹Xerox|Mercedes|Santander|AbbeyRoadInst|Chatsworth|Ernst&Young|Omnisport|PinsentMasons
https://www.dbmmgroup.com/wp-content/uploads/2024/03/DBMM_Creds_Deck_2024_2.pdf
https://investorshub.advfn.com/uimage/uploads/2024/12/23/betnvDBMM
DBMM
Involuntary-Recluse Involuntary-Recluse 4 minutes ago
Not really T, anyone that took those court jesters seriously should have their heads examined....
Lies on top of lies for years. Good riddance to them and their penny ante stakes 😂 folks like that get nowhere in life in a hurry ;-)

I could probably expose Andrew Pinocc
DJPele DJPele 4 minutes ago
Sheesh, get a grip
NWBO
ORCA ORCA 5 minutes ago
HEY PANTY MAN.SELL MAN SELL.
VDRM
janice shell janice shell 5 minutes ago
Not nearly as good. Ronzoni, I mean.
doubbleup doubbleup 6 minutes ago
With all the great things going on at SideChannel (new hires, sales, product development, etc). I find it perplexing we are getting no attention from any people wanting to invest. It's like we're not on any radar.
SDCH
RobotDroid RobotDroid 8 minutes ago
Sell the news or stay a linda made bagholder.
NWBO
nowwhat2 nowwhat2 9 minutes ago
Oh..... I didn't know that........So to "bypass" the order they'll simply "rename" the region ?
Biden, did an executive order stopping drilling for oil in the Gulf of Mexico.
So to "bypass" the order they'll simply "rename" the region ?
That's pretty....."wild" !
Sheepdog Sheepdog 9 minutes ago
While that is again a false statement, funny how all of those stocks that were called scams turned out to be scams. More funny is that all the stocks that have been deemed by some as "going to the moon" also turned out to be scams.
GCAN
JoshTaeger JoshTaeger 9 minutes ago
You can be mystified about Hindenberg all you want. It has nothing to do with that shell company NoRide.

And you keep saying NDA. I don't think that means what you think it means.

BWAHAHAHA!!!

Stock Flops 2...SG 0.
NRDE
DonVance DonVance 9 minutes ago
The wallet behind world liberty financial just bought a bunch of BTC recently.
BTCUSD
cadillacdave cadillacdave 11 minutes ago
Dont worry, the government will be all in on quantum. They will find many uses for it and maintaining military superiority will be at the top of that list.

Nefarious uses won't be limited to private industry. The political class will want an edge as well.
IONQ
WhAtEvA1 WhAtEvA1 11 minutes ago
All fine and dandy for investors hoping to make quick money but do you factor in the possibility (a high one at that IMO) that Korenko likely won't be selling for measly $1B? Given the toil and years of sweat into Vivos/radiogel/Isopet, I just don't see Korenko entertaining a selling price that low;
RDGL